Update on Treatment Options for Gonococcal Infections.

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• The incidence of Neisseria gonorrhoeae infections has increased significantly in the United States over the past decade.
• Multidrug-resistant strains of N. gonorrhoeae are emerging, posing a serious threat to public health.
• Current treatment guidelines recommend dual therapy, but resistance to these agents is a growing concern.

Purpose of the Study:

• To review currently available and investigational agents for treating Neisseria gonorrhoeae infections.
• To provide recommendations for the management of gonococcal infections in light of rising resistance.
• To address the potential public health crisis associated with untreatable gonorrhea.

Main Methods:

• Review of current literature on Neisseria gonorrhoeae treatment.
• Analysis of data on antimicrobial resistance patterns.
• Evaluation of agents currently in clinical trials for gonorrhea treatment.

Main Results:

• The incidence of gonorrhea has increased by nearly 10% in the last 5 years.
• Resistance to components of the recommended dual therapy regimen is high.
• Ceftriaxone resistance has not yet been reported in the US but is anticipated.

Conclusions:

• Untreatable gonorrhea presents a significant public health challenge with severe patient sequelae.
• New antimicrobial agents are crucial to combat emerging resistance.
• Proactive management strategies and the development of novel treatments are essential.